
Europe Lateral Flow Assays Market By type (Kits & Reagents and Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), By Sample Type (Blood Samples, Urine Samples, Saliva Samples, and Other Samples), By
Description
Europe Lateral Flow Assays Market By type (Kits & Reagents and Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), By Sample Type (Blood Samples, Urine Samples, Saliva Samples, and Other Samples), By Application (Clinical Testing, Drug Development & Quality Testing, Veterinary Diagnostics, and Food Safety & Environmental Testing), By End User (Hospitals & Clinics, Diagnostics Laboratories, Pharmaceuticals & Biotechnology Companies, Home Care Settings, and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
The Europe Lateral Flow Assays Market would witness market growth of 2.1% CAGR during the forecast period (2021-2027).
Technical advances in the area of lateral flow assays (LFA) have also contributed to market expansion. Novel signal amplification techniques, the introduction of new labels, enhanced quantification systems, and concurrent detection have all supported the significant improvements in LFA development in recent years. New strategies have been developed to improve the signal from gold nanoparticles (colloidal nanoparticles) GNPs have been enhanced with silver or combined with an enzyme (like horseradish peroxidase), resulting in catalytic amplification of the signal.
HIV/AIDS prevention, treatment, and care are gaining more significance in Europe over the last few decades. In the WHO European Region, where no country has been spared, more than two million individuals are infected with the disease. Despite the fact that this number is low when compared to the worst-affected region, it marks an unprecedented spike in new cases. The rapid spread of HIV in Eastern Europe, in particular, is one of the region's most pressing public health issues. Three eastern European countries have gone from a few reported cases to an estimated HIV prevalence of more than 1% among adults aged 15–49 in the last ten years. Since lateral flow assays are widely used to check test and evaluate various diseases including HIV, the demand for these assays would increase among various healthcare institutions.
The Germany market dominated the Europe Lateral Flow Assays Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $919.5 million by 2027. The UK market is poised to grow at a CAGR of 1.3% during (2021 - 2027). Additionally, The France market would showcase a CAGR of 2.8% during (2021 - 2027).
Based on type, the market is segmented into Kits & Reagents and Lateral Flow Readers. Based on Technique, the market is segmented into Sandwich Assays, Competitive Assays, and Multiplex Detection Assays. Based on Sample Type, the market is segmented into Blood Samples, Urine Samples, Saliva Samples , and Other Samples. Based on Application, the market is segmented into Clinical Testing, Drug Development & Quality Testing, Veterinary Diagnostics, and Food Safety & Environmental Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostics Laboratories, Pharmaceuticals & Biotechnology Companies, Home Care Settings , and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens AG, PerkinElmer, Inc., and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments covered in the Report:
By Type
The Europe Lateral Flow Assays Market would witness market growth of 2.1% CAGR during the forecast period (2021-2027).
Technical advances in the area of lateral flow assays (LFA) have also contributed to market expansion. Novel signal amplification techniques, the introduction of new labels, enhanced quantification systems, and concurrent detection have all supported the significant improvements in LFA development in recent years. New strategies have been developed to improve the signal from gold nanoparticles (colloidal nanoparticles) GNPs have been enhanced with silver or combined with an enzyme (like horseradish peroxidase), resulting in catalytic amplification of the signal.
HIV/AIDS prevention, treatment, and care are gaining more significance in Europe over the last few decades. In the WHO European Region, where no country has been spared, more than two million individuals are infected with the disease. Despite the fact that this number is low when compared to the worst-affected region, it marks an unprecedented spike in new cases. The rapid spread of HIV in Eastern Europe, in particular, is one of the region's most pressing public health issues. Three eastern European countries have gone from a few reported cases to an estimated HIV prevalence of more than 1% among adults aged 15–49 in the last ten years. Since lateral flow assays are widely used to check test and evaluate various diseases including HIV, the demand for these assays would increase among various healthcare institutions.
The Germany market dominated the Europe Lateral Flow Assays Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $919.5 million by 2027. The UK market is poised to grow at a CAGR of 1.3% during (2021 - 2027). Additionally, The France market would showcase a CAGR of 2.8% during (2021 - 2027).
Based on type, the market is segmented into Kits & Reagents and Lateral Flow Readers. Based on Technique, the market is segmented into Sandwich Assays, Competitive Assays, and Multiplex Detection Assays. Based on Sample Type, the market is segmented into Blood Samples, Urine Samples, Saliva Samples , and Other Samples. Based on Application, the market is segmented into Clinical Testing, Drug Development & Quality Testing, Veterinary Diagnostics, and Food Safety & Environmental Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostics Laboratories, Pharmaceuticals & Biotechnology Companies, Home Care Settings , and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens AG, PerkinElmer, Inc., and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments covered in the Report:
By Type
- Kits & Reagents
- Lateral Flow Readers
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
- Blood Samples
- Urine Samples
- Saliva Samples
- Other Samples
- Clinical Testing
- Drug Development & Quality Testing
- Veterinary Diagnostics
- Food Safety & Environmental Testing
- Hospitals & Clinics
- Diagnostics Laboratories
- Pharmaceuticals & Biotechnology Companies
- Home Care Settings
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Quidel Corporation
- Siemens AG
- PerkinElmer, Inc.
- F. Hoffmann-La Roche Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
139 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Lateral Flow Assays Market, by Type
- 1.4.2 Europe Lateral Flow Assays Market, by Technique
- 1.4.3 Europe Lateral Flow Assays Market, by Sample Type
- 1.4.4 Europe Lateral Flow Assays Market, by Application
- 1.4.5 Europe Lateral Flow Assays Market, by End User
- 1.4.6 Europe Lateral Flow Assays Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations, Approvals and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Sep – 2022, Jan) Leading Players
- Chapter 4. Europe Lateral Flow Assays Market by Type
- 4.1 Europe Kits & Reagents Market by Country
- 4.2 Europe Lateral Flow Readers Market by Country
- Chapter 5. Europe Lateral Flow Assays Market by Technique
- 5.1 Europe Sandwich Assays Market by Country
- 5.2 Europe Competitive Assays Market by Country
- 5.3 Europe Multiplex Detection Assays Technique Market by Country
- Chapter 6. Europe Lateral Flow Assays Market by Sample Type
- 6.1 Europe Blood Samples Market by Country
- 6.2 Europe Urine Samples Market by Country
- 6.3 Europe Saliva Samples Market by Country
- 6.4 Europe Other Samples Market by Country
- Chapter 7. Europe Lateral Flow Assays Market by Application
- 7.1 Europe Clinical Testing Market by Country
- 7.2 Europe Drug Development & Quality Testing Market by Country
- 7.3 Europe Veterinary Diagnostics Market by Country
- 7.4 Europe Food Safety & Environmental Testing Market by Country
- Chapter 8. Europe Lateral Flow Assays Market by End User
- 8.1 Europe Hospitals & Clinics Market by Country
- 8.2 Europe Diagnostics Laboratories Market by Country
- 8.3 Europe Pharmaceuticals & Biotechnology Companies Market by Country
- 8.4 Europe Home Care Settings Market by Country
- 8.5 Europe Others Market by Country
- Chapter 9. Europe Lateral Flow Assays Market by Country
- 9.1 Germany Lateral Flow Assays Market
- 9.1.1 Germany Lateral Flow Assays Market by Type
- 9.1.2 Germany Lateral Flow Assays Market by Technique
- 9.1.3 Germany Lateral Flow Assays Market by Sample Type
- 9.1.4 Germany Lateral Flow Assays Market by Application
- 9.1.5 Germany Lateral Flow Assays Market by End User
- 9.2 UK Lateral Flow Assays Market
- 9.2.1 UK Lateral Flow Assays Market by Type
- 9.2.2 UK Lateral Flow Assays Market by Technique
- 9.2.3 UK Lateral Flow Assays Market by Sample Type
- 9.2.4 UK Lateral Flow Assays Market by Application
- 9.2.5 UK Lateral Flow Assays Market by End User
- 9.3 France Lateral Flow Assays Market
- 9.3.1 France Lateral Flow Assays Market by Type
- 9.3.2 France Lateral Flow Assays Market by Technique
- 9.3.3 France Lateral Flow Assays Market by Sample Type
- 9.3.4 France Lateral Flow Assays Market by Application
- 9.3.5 France Lateral Flow Assays Market by End User
- 9.4 Russia Lateral Flow Assays Market
- 9.4.1 Russia Lateral Flow Assays Market by Type
- 9.4.2 Russia Lateral Flow Assays Market by Technique
- 9.4.3 Russia Lateral Flow Assays Market by Sample Type
- 9.4.4 Russia Lateral Flow Assays Market by Application
- 9.4.5 Russia Lateral Flow Assays Market by End User
- 9.5 Spain Lateral Flow Assays Market
- 9.5.1 Spain Lateral Flow Assays Market by Type
- 9.5.2 Spain Lateral Flow Assays Market by Technique
- 9.5.3 Spain Lateral Flow Assays Market by Sample Type
- 9.5.4 Spain Lateral Flow Assays Market by Application
- 9.5.5 Spain Lateral Flow Assays Market by End User
- 9.6 Italy Lateral Flow Assays Market
- 9.6.1 Italy Lateral Flow Assays Market by Type
- 9.6.2 Italy Lateral Flow Assays Market by Technique
- 9.6.3 Italy Lateral Flow Assays Market by Sample Type
- 9.6.4 Italy Lateral Flow Assays Market by Application
- 9.6.5 Italy Lateral Flow Assays Market by End User
- 9.7 Rest of Europe Lateral Flow Assays Market
- 9.7.1 Rest of Europe Lateral Flow Assays Market by Type
- 9.7.2 Rest of Europe Lateral Flow Assays Market by Technique
- 9.7.3 Rest of Europe Lateral Flow Assays Market by Sample Type
- 9.7.4 Rest of Europe Lateral Flow Assays Market by Application
- 9.7.5 Rest of Europe Lateral Flow Assays Market by End User
- Chapter 10. Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.1.5.2 Product Launches and Product Expansions:
- 10.2 Becton, Dickinson and Company
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Partnerships, Collaborations, and Agreements:
- 10.3 Hologic, Inc.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.3.5.2 Product Launches and Product Expansions:
- 10.4 Thermo Fisher Scientific, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.4.5.2 Geographical Expansions:
- 10.4.6 SWOT Analysis
- 10.5 F. Hoffmann-La Roche Ltd.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.5.5.2 Product Launches and Product Expansions:
- 10.6 Danaher Corporation
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expense
- 10.7 Bio-Rad laboratories, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Product Launches and Product Expansions:
- 10.8 Quidel Corporation
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expense
- 10.8.5 Recent strategies and developments:
- 10.8.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.8.5.2 Acquisition and Mergers:
- 10.8.5.3 Geographical Expansions:
- 10.9 Siemens AG
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expense
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.9.5.2 Product Launches and Product Expansions:
- 10.9.6 SWOT Analysis
- 10.10. PerkinElmer, Inc.
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Segmental and Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
- 10.10.5.1 Partnerships, Collaborations, Approvals and Agreements:
- 10.10.5.2 Product Launches and Product Expansions:
- 10.10.5.3 Acquisition and Mergers:
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.